USFDA Flags Misleading Claims on Compounded Semaglutide, Tirzepatide Products sheeba farhat22 Jun 2026 5:24 PM ISTBengaluru: The U.S. Food and Drug Administration issued 25 warning letters to telehealth companies for marketing false and misleading claims about...
India's GLP-1 Market Nears Rs 2,000 Crore as Semaglutide Boom Slows, Tirzepatide Regains Momentum Susmita Roy21 Jun 2026 12:45 PM ISTNew Delhi: India's rapidly expanding GLP-1 agonist market is entering a new phase of maturity, with the explosive growth triggered by semaglutide...
Novo Nordisk Seeks Ban on Unregistered Semaglutide Products in South Africa sheeba farhat11 Jun 2026 6:07 PM ISTPretoria: Danish drugmaker Novo Nordisk is heading to court in South Africa on Wednesday to try to halt the sale of unapproved copies of semaglutide,...
From Digene to Glimstar, Prices of Common Medicines Rise by Up to 10% Parthika Patel13 May 2026 9:07 PM ISTNew Delhi: Prices of several commonly used allopathic medicines, including those for blood pressure, diabetes, liver ailments, acidity and children's...
Typo Errors, Colour Mismatch Lead to Bust of Fake Mounjaro in Gurugram sheeba farhat24 April 2026 10:45 AM ISTGurugram: Colour dissimilarity to typographical errors, conspicuous differences in the packaging of counterfeit Mounjaro injections led the Drugs...
Hetero Targets 1.5 Million Semaglutide Pens, Eyes 75+ Markets sheeba farhat16 April 2026 8:30 PM ISTHyderabad: Hetero Labs, one of India's largest privately held drugmakers, aims to sell 1.5 ​million pens of generic weight-loss and diabetes drugs in...
Lupin Gets USFDA Approval for Xigduo XR Generic Dapagliflozin-Metformin Tablets Parthika Patel10 April 2026 9:14 PM ISTNew Delhi: Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and Metformin...
Rajasthan Orders Recall of Substandard Drugs Including Ofloxacin, Voglibose After Quality Failures Parthika Patel22 Dec 2025 1:33 PM ISTJaipur: In a serious public health action, the Rajasthan Drug Control Department has busted the supply of substandard medicines used for diabetes,...
Diabetes Drug Bladder Cancer Risk Debate: Madras HC Orders Expert Review on Pioglitazone, Sitagliptin Safety Susmita Roy16 Dec 2025 3:30 PM ISTNew Delhi: The Madras High Court has directed the Union Ministry of Health and Family Welfare to constitute a team of medical experts to examine the...
Bombay High Court Blocks Use of Deceptively Similar Diabetes Drug Trademark Susmita Roy19 Nov 2025 10:14 PM ISTMumbai: In a ruling reinforcing the protection of pharmaceutical trademarks, the Bombay High Court has granted interim relief to Laboratories Griffon,...
Expert Panel Rejects Zuventus' Trelagliptin PMS Plan, Seeks Higher Patient Enrolment Parthika Patel18 Aug 2025 2:37 PM ISTNew Delhi: Zuventus Healthcare Limited's proposal for the active post-marketing surveillance (PMS) study of Trelagliptin Tablets 25 mg, 50 mg and 100...
CDSCO Panel Approves New Indications for Novo Nordisk's Semaglutide, Mandates PMS Study Susmita Roy9 Aug 2025 12:18 PM ISTNew Delhi: Recommending to conduct post marketing surveillance (PMS) study in India, the Subject Expert Committee (SEC) functional under the Central...
